SHPH: Shuttle Pharmaceuticals Holdings, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2.28
Enterprise Value ($M) 1.24
Book Value ($M) 0.71
Book Value / Share 0.17
Price / Book 3.22
NCAV ($M) 0.41
NCAV / Share 0.10
Price / NCAV 5.51

Profitability (mra)
Return on Invested Capital (ROIC) -4.86
Return on Assets (ROA) -1.54
Return on Equity (ROE) -2.25

Liquidity (mrq)
Quick Ratio 1.44
Current Ratio 1.44

Balance Sheet (mrq) ($M)
Current Assets 2.21
Assets 2.51
Liabilities 1.80
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -7.70
Net Income -9.14

Cash Flow Statement (mra) ($M)
Cash From Operations -7.33
Cash from Investing 2.92
Cash from Financing 3.76

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G Armistice Capital, Llc 7.51

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-09-04 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)
2024-09-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-09-04 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 292,220 838,924 34.83
2025-03-06 805 12,523 6.43
2025-03-05 7,854 33,824 23.22
2025-03-04 6,991 38,715 18.06

(click for more detail)

Similar Companies
SBFM – Sunshine Biopharma, Inc. SCLX – Scilex Holding Company
SGMO – Sangamo Therapeutics, Inc. SILO – Silo Pharma, Inc.
SLGL – Sol-Gel Technologies Ltd.


Financial data and stock pages provided by
Fintel.io